{"id":"https://genegraph.clinicalgenome.org/r/74e151f3-71fd-463c-a3e3-99bde62c0497v1.2","type":"EvidenceStrengthAssertion","dc:description":"Variants in the *IMPDH1* gene were first identified as the cause of autosomal dominant cases of retinitis pigmentosa 10 (MIM#: 180105) in 2002 (PMID: 11875050) and account for ~2-3% of all retinitis pigmentosa cases (PMID: 37259572). Disease-causing IMPDH1 variants reportedly have dominant negative effects, consistent with the observation that *Impdh1* knock-out mice exhibit only a mild retinopathy (PMID: 14981049). *IMPDH1* variants have also been asserted in relation to autosomal dominant cases of Leber congenital amaurosis 11 (PMID: 16384941). Per criteria outlined by the ClinGen Lumping & Splitting Working Group, the mode of inheritance (autosomal dominant) and molecular mechanism (monoallelic dominant negative *IMPDH1* variants) have been found to be consistent among patients diagnosed with either retinitis pigmentosa 10 (MIM# 180105) or Leber congenital amaurosis 11 (MIM# 613837), while the phenotypic variability between cases appears to represent a spectrum of disease rather than separate disease entities. Therefore, cases caused by inherited biallelic *IMPDH1* variants have been lumped into a single disease entity, referred to as IMPDH1-related retinopathy.\n\nAt least 10 *IMPDH1* variants (9 missense changes and 1 in-frame deletion of a single amino acid) have been associated with autosomal dominant retinitis pigmentosa or Leber congenital amaurosis. These forms of IMPDH1-related retinopathy generally present with night blindness and visual field constriction that progress gradually to loss of central vision (PMID: 11875050, PMID: 11875049, PMID: 34813793, PMID: 15851576, PMID: 37259572). Two recurrent variants, c.926G>C (p.Arg309Pro) and c.676G>A, (p.Asp226Asn), have been reported in numerous affected individuals (PMID: 37259572). This curation has collected data from 17 individuals and 2 families with 17 unique variants (PMID: 11875049, PMID: 11875050, PMID: 34813793, PMID: 15851576, PMID: 37259572).\n\nThis gene-disease relationship is also supported by experimental evidence in the form of expression, biochemical function, animal modelling and function alteration data linking the *IMPDH1* gene and its protein product to retinal disease (PMID: 14981049, PMID: 11875049, PMID: 34813793). *IMPDH1* (inosine monophosphate dehydrogenase 1) encodes a critical enzyme involved in the generation of the purine base guanine (PMID: 11875049; PMID: 37259572). Despite the housekeeping function of IMPDH1, it is expressed at higher levels in the retina, which is an energy-demanding tissue that requires high generation of both ATP and GTP. The IMPDH1 protein supplies GTP to photoreceptor cells and is allosterically regulated based on changes in illumination to control GTP availability (PMID: 14981049, PMID: 34813793, PMID: 37259572).\n\nIn summary, *IMPDH1* is definitively associated with autosomal dominant IMPDH1-related retinopathy This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time without the emergence of conflicting evidence. This clinical validity classification was approved by the ClinGen Retina Gene Curation Expert Panel on February 1st, 2024 (SOP version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/74e151f3-71fd-463c-a3e3-99bde62c0497","GCISnapshot":"https://genegraph.clinicalgenome.org/r/04d85991-25a4-4da6-8090-65b8cfb771cd","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/04d85991-25a4-4da6-8090-65b8cfb771cd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2025-01-04T02:20:30.223Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/04d85991-25a4-4da6-8090-65b8cfb771cd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2024-02-01T17:00:00.000Z","role":"Approver"}],"curationReasons":["DiseaseNameUpdate"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04d85991-25a4-4da6-8090-65b8cfb771cd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3d754dc-f91f-4afc-9202-6f570c34030c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3d754dc-f91f-4afc-9202-6f570c34030c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23534816","allele":{"id":"https://genegraph.clinicalgenome.org/r/ef73a0c6-91b2-4037-be0a-9208dcefa7aa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.809T>G (p.Leu270Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369172172"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/97dbc4c3-a7eb-4737-b047-045b0b9adcbc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97dbc4c3-a7eb-4737-b047-045b0b9adcbc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30718709","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ca813b5-fe7c-4f90-b668-2ae4c6ec5080","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.978G>C (p.Gln326His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369168838"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/143e8662-5aaf-4efd-8edf-bc25fde14a82","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/143e8662-5aaf-4efd-8edf-bc25fde14a82_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37259572","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f57431e-8a3c-4f95-9f77-0bc754ab3cbd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.940A>C (p.Lys314Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369169337"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0a40fb65-ba81-4716-ae5c-752386b35d16","type":"EvidenceLine","dc:description":"Reccurent variant which was recorded in almost 10 indepedent studies and more than 15 different families PMID: 37259572.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a40fb65-ba81-4716-ae5c-752386b35d16_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11875049","allele":{"id":"https://genegraph.clinicalgenome.org/r/3d0f4332-52ed-4905-823a-6c1cad6715d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.926G>C (p.Arg309Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257385"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0a40fb65-ba81-4716-ae5c-752386b35d16_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Following a 32P-densitometry analysis, the data showed that the mutations and R224P (R309P) significantly reduced phosphorylation of IMPDH1 by PKCa. Blindness associated mutations R224P were introduced by site-directed mutagenesis in the pETEV15b_HsIMPDH1(546) vector. PMID: 32254022","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/340bd4d5-b38b-47b0-91bf-ba53e61f0aa1","type":"EvidenceLine","dc:description":"Reccurent variant which was recorded in almost 11 indepedent studies and more than 20 different families PMID: 37259572.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/340bd4d5-b38b-47b0-91bf-ba53e61f0aa1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11875050","allele":{"id":"https://genegraph.clinicalgenome.org/r/6f0ac16b-41e1-4ee8-8c2c-e6377688831a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.931G>A (p.Asp311Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257369"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c0312210-528b-4879-a8a7-b0e27d2409fc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0312210-528b-4879-a8a7-b0e27d2409fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661368","allele":{"id":"https://genegraph.clinicalgenome.org/r/e030bcd9-afe0-477d-b3ae-49cd14fa09af","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.592G>T (p.Gly198Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369173965"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c6cdc4db-59ed-49dd-866a-3f3f7e6780e4","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6cdc4db-59ed-49dd-866a-3f3f7e6780e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34813793","allele":{"id":"https://genegraph.clinicalgenome.org/r/8e97bdb4-835c-4480-ae9a-e4a4feb565a1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.968A>G (p.Lys323Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369169029"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4fb067ef-eb12-48c9-83c2-816501443b2d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4fb067ef-eb12-48c9-83c2-816501443b2d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32795431","allele":{"id":"https://genegraph.clinicalgenome.org/r/6f30c923-7cc8-4a9c-9cd5-fcf4b62afb18","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.1603A>G (p.Lys535Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4470774"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f8b19e8d-fa42-4402-8c1c-e05235c75419","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8b19e8d-fa42-4402-8c1c-e05235c75419_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35456422","allele":{"id":"https://genegraph.clinicalgenome.org/r/93c6a063-1a6b-4a98-80c9-6866fe401d0c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.527T>C (p.Ile176Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369174186"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2cb80570-58f3-4de6-8046-d1d7a87fb25c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cb80570-58f3-4de6-8046-d1d7a87fb25c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32483926","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa890cbe-54e5-4dcf-879c-cd2d7ea9109c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.933C>G (p.Asp311Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369169397"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ba03fcd7-6832-42ba-9c76-f855a353ce2c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba03fcd7-6832-42ba-9c76-f855a353ce2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16384941","allele":{"id":"https://genegraph.clinicalgenome.org/r/f2ce1e59-1c27-4810-bfb9-ee3f8fbc2d80","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.849T>A (p.Asn283Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369171839"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a593a70a-053e-4c35-82d3-b2383d34158c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a593a70a-053e-4c35-82d3-b2383d34158c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34813793","allele":{"id":"https://genegraph.clinicalgenome.org/r/7735a6e1-491e-46a7-9942-c0e609fe7632","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.935T>C (p.Leu312Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369169375"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1fd174d5-2999-42ef-af2a-0a1fd334c21c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1fd174d5-2999-42ef-af2a-0a1fd334c21c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26720483","allele":{"id":"https://genegraph.clinicalgenome.org/r/f59555ad-f930-46b9-98af-dbe854d6dbd8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.984G>C (p.Gln328His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10586358"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5a14cd43-f9f8-4a9d-8e8c-d8081e33b688","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a14cd43-f9f8-4a9d-8e8c-d8081e33b688_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25412400","allele":{"id":"https://genegraph.clinicalgenome.org/r/0ee74466-0818-4b96-a2c7-af8f6bd7aae7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.962C>T (p.Ala321Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369169078"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f3fd5257-67c0-4442-803c-eb270c272c88","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3fd5257-67c0-4442-803c-eb270c272c88_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29844330","allele":{"id":"https://genegraph.clinicalgenome.org/r/a95c4b7a-0ece-468e-8095-81d00c028b69","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.590A>C (p.Gln197Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369173975"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d1b0309c-b1bd-495d-9888-7cc088e59251","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1b0309c-b1bd-495d-9888-7cc088e59251_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24791140","allele":{"id":"https://genegraph.clinicalgenome.org/r/54a53340-c64b-46d1-810a-a9170d3d2771","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.942_944del (p.Lys314del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658683499"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/04d85991-25a4-4da6-8090-65b8cfb771cd_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39da5ebf-ae20-447a-8d5a-8717c6cf4f8f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11875050","rdfs:label":"UTAD045","estimatedLodScore":4.52,"family":{"id":"https://genegraph.clinicalgenome.org/r/39da5ebf-ae20-447a-8d5a-8717c6cf4f8f","type":"Family","rdfs:label":"UTAD045","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c03cf879-a1ed-4d30-8a2a-82a8e1707632","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11875050","rdfs:label":"UTAD-045","allele":{"id":"https://genegraph.clinicalgenome.org/r/6f0ac16b-41e1-4ee8-8c2c-e6377688831a"},"detectionMethod":"Multipoint linkage analysis was conducted using the MLINK and LINKMAP programs in the LINKAGE program package optimized for fast sequential computations on a Sun SPARCstation IPC. Multi-allelic microsatellite markers were recoded to mini- mize the number of alleles evaluated.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Linkage analysis","phenotypes":"obo:HP_0000510","previousTesting":true,"previousTestingDescription":"Microsatellite typing and linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/340bd4d5-b38b-47b0-91bf-ba53e61f0aa1_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":16,"phenotypes":"obo:HP_0000510","proband":{"id":"https://genegraph.clinicalgenome.org/r/c03cf879-a1ed-4d30-8a2a-82a8e1707632"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/9cb9e4f8-8b2a-4b4b-b7ba-86ff315e7961_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24791140","rdfs:label":"Family-012","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/9cb9e4f8-8b2a-4b4b-b7ba-86ff315e7961","type":"Family","rdfs:label":"Family-012","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/5b3c85c6-68e3-4936-b80b-88d3f2abbd17","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24791140","rdfs:label":"III4","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/54a53340-c64b-46d1-810a-a9170d3d2771"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000662","obo:HP_0032037","obo:HP_0007791","obo:HP_0007994"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d1b0309c-b1bd-495d-9888-7cc088e59251_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0007994","obo:HP_0007791","obo:HP_0000662","obo:HP_0032037"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5b3c85c6-68e3-4936-b80b-88d3f2abbd17"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.8},{"id":"https://genegraph.clinicalgenome.org/r/c9dfc22c-8e89-4736-ad5e-37e379d108cf","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9dfc22c-8e89-4736-ad5e-37e379d108cf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31106028","allele":{"id":"https://genegraph.clinicalgenome.org/r/f101cd77-aada-4b1b-bf30-f7ba4c9b0c4f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000883.4(IMPDH1):c.727G>A (p.Val243Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4471073"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7.1},{"id":"https://genegraph.clinicalgenome.org/r/04d85991-25a4-4da6-8090-65b8cfb771cd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04d85991-25a4-4da6-8090-65b8cfb771cd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2a4d69e-4d67-4cde-b176-d5cf1628a565","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51013a2b-b7f4-4984-bab0-60e45777a462","type":"Finding","dc:description":"We demonstrate biochemical and structural similarity between the zebrafish and human retinal variant of IMPDH1, uncover dynamic changes in photoreceptor filaments throughout the day, and use metabolomics to elucidate an important role for Impdh1 in purine nucleotide homeostasis in photoreceptors. In zebrafish, gene subfunctionalization due to ancestral duplication resulted in a predominant retinal variant expressed exclusively in rod and cone photoreceptors. This variant is structurally and functionally similar to the human IMPDH1 retinal variant and shares a reduced sensitivity to GTP-mediated inhibition. We also demonstrated that Impdh1a forms prominent protein filaments in vitro and in vivo in both rod and cone photoreceptor cell bodies, synapses, and to a lesser degree, in outer segments","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34813793","rdfs:label":"IMPDH expression in zebrafish retina","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6b2990cb-9615-46c5-9e48-2dd19ede0d40","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53d25b94-d645-4530-8877-173bdc4cd061","type":"Finding","dc:description":"In order to assess expression patterns of IMPDH1, IMPDH2 and HPRT in retinal tissues, in situ hybridizations were carried out using riboprobes specific for transcripts derived from these genes on mouse retinal cryosections. EST data obtained for the IMPDH2 gene indicate that this isoenzyme is expressed in retinal pigment epithelium (RPE) libraries, hence Impdh2 in situ hybridizations were performed on retinal sections from CD1 mice, which do not possess pigment in the RPE. The results of this analysis indicate that Impdh1 is preferentially and strongly expressed within photoreceptor cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14981049","rdfs:label":"Impdh and Hprt expression in the murine retina","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fe6edde8-d565-40ac-8a0a-ebf8c62e4b94","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc889d6e-d76f-4cd2-8ce6-cf61b8862bc5","type":"Finding","dc:description":"Mutations associated with human retinopathies map into the guanine nucleotide-binding sites including a previously undescribed non-canonical site and disrupt allosteric inhibition. Together, the results shed light on the mechanisms of the allosteric regulation of enzymes mediated by Bateman domains and provide a molecular basis for certain retinopathies.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26558346","rdfs:label":"IMPDH activity assay and enzyme kinetics","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3caa0dd9-82be-4aaa-99c4-f030e973fce3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1ff615a-835e-4a74-b086-18ec09459de6","type":"Finding","dc:description":"The gene encoding inosine monophosphate dehydrogenase type 1 (IMPDH1), which showed an average down-regulation of 5.8-fold in the Rho–/– retina, maps to the precise location of the RP10 locus. There were no other genes in the disease interval which showed a similar down-regulation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11875049","rdfs:label":"Microarray-based transcriptional analysis ","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/04d85991-25a4-4da6-8090-65b8cfb771cd_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0350ded2-adf8-4bc2-a31c-12b7d7fa882a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05afaf86-1d42-4f3e-bb76-12f24c3c3a02","type":"FunctionalAlteration","dc:description":"Mutant IMPDH1 proteins were found to exhibit marked decreased solubility in comparison to wild-type when expressed at a temperature of 37oC in bacterial cells (data not shown). In order to investigate this observation further, human embryonic kidney (HEK) 293T cells were transfected with mammalian expression constructs containing wild-type, Arg224Pro or Asp226Asn mutant IMPDH1 sequences, with incorporation of a His-tag for protein detection purposes. After harvesting, cells were separated into total cell protein, soluble cytosolic, nuclear and insoluble pelleted fractions, which were subsequently analysed by SDS–PAGE electrophoresis and western blotting. Wild-type and mutant IMPDH1 proteins were expressed at similarly high levels in whole cell extracts with a band clearly visible at 55kDa. No protein band of this size was evident in cells transfected with a construct that did not contain an IMPDH1 cDNA insert. Following analysis of cellular fractions obtained after further purification steps, wild-type IMPDH1 protein was shown to localize in the soluble cytosolic fraction, while no mutant protein was detectable in this fraction. Both mutant proteins exhibited considerably decreased solubility and as a result almost all of the mutant protein localized in the final pellet, which was re-suspendable in strong denaturant. Accordingly, they hypothesize that such mutant IMPDH1 proteins may be mis-folded, resulting in the formation of insoluble aggregates within the cell cytosol.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14981049","rdfs:label":"Expression of wild-type and mutant His-tagged IMPDH1 in HEK "}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/04d85991-25a4-4da6-8090-65b8cfb771cd_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56181cb4-a7a7-4677-ae60-2610e0facfc8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e997d2e6-6217-4c98-8afa-5b586d4111e9","type":"Finding","dc:description":"Impdh1-/- null mice are shown here to display a slowly progressive form of retinal degeneration in which visual transduction, analysed by electroretinographic wave functions, becomes gradually compromised, although at 12 months of age most photoreceptors remain structurally intact. In contrast, the human form of RP caused by mutations within the IMPDH1 gene is a severe autosomal dominant degenerative retinopathy in those families that have been examined to date.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14981049","rdfs:label":"Retinal structure and function in Impdh1-/- mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Definitive","sequence":9653,"specifiedBy":"GeneValidityCriteria10","strengthScore":11.6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/_blapEAlYuc","type":"GeneValidityProposition","disease":"obo:MONDO_1040051","gene":"hgnc:6052","modeOfInheritance":"obo:HP_0000006"},"version":"1.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_04d85991-25a4-4da6-8090-65b8cfb771cd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}